Latest filing published 03 Nov 2025 for BIO-TECHNE Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Joseph d. Keegan is a declared insider at 2 companies (board member); the most frequent names are BIO-TECHNE Corp and Interpace Biosciences, Inc. We count 6 filings; the first trade dates from 3 February 2016 and the latest from 30 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 3 November 2025, reports a share grant in BIO-TECHNE Corp. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations